Drug Trial Radar · NCT05776277
Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury
Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Mar 21, 2024
Primary completion
Dec 2026
Study completion Dec 2027
Sponsor
- Lead sponsor
- Cook MyoSiteIndustry
- Sponsor type
- Industry
- First posted
- Mar 20, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates the efficacy and safety of a single injection of iltamiocel (300 x 10\^6 cells) compared to a placebo in the reduction of fecal incontinence episode frequency in adult female participants with chronic fecal incontinence and a history of obstetric anal sphincter injury. Half of the participants will receive iltamiocel (injections with cells) and the other half will receive placebo.
Conditions
- Fecal Incontinence
Interventions
IltamiocelBiological
Single external anal sphincter (EAS) injection of 300 x 10\^6 cells.
PlaceboOther
Placebo control is the vehicle solution used for the study product.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes in frequency of fecal incontinence episodes.Time frame: 12 Months
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
UC San Diego Health
La Jolla, California
UC Irvine Medical Center
Orange, California
University of California, San Francisco - Center for Colorectal Surgery
San Francisco, California
Prestige Medical Group
Tustin, California
American Association of Female Pelvic Medicine
Westlake Village, California
University of Florida Shands Hospital
Gainesville, Florida
Healthcare Clinical Data, Inc.
Miami, Florida
Orlando Health Colon & Rectal Institute
Orlando, Florida
USF Health South Tampa Center for Advanced Healthcare
Tampa, Florida
Colorectal Wellness Center
Fayetteville, Georgia
University of Illinois
Chicago, Illinois
Franciscan Health Indianapolis
Indianapolis, Indiana
Ochsner Health
New Orleans, Louisiana
Massachusetts General Hospital
Boston, Massachusetts
Bennett Institute of Urogynecology and Incontinence
Grand Rapids, Michigan
University of Minnesota
Minneapolis, Minnesota
Mayo Clinic
Rochester, Minnesota
Washington University School of Medicine
St Louis, Missouri
Rutgers, Robert Wood Johnson Medical School, Clinical Research Center
New Brunswick, New Jersey
Westchester Medical Center
Hawthorne, New York
The Mount Sinai Medical Center
New York, New York
Weill Cornell Medicine
New York, New York
Stony Brook University Hospital
Stony Brook, New York
Cleveland Clinic Main Campus Crile Building
Cleveland, Ohio
Rhode Island Hospital
Providence, Rhode Island
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.